Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.71)
# 785
Out of 5,042 analysts
135
Total ratings
56.82%
Success rate
4.99%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $28.53 | +5.15% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $436.62 | +32.84% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $362.50 | -10.34% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $34.07 | +26.21% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $290.65 | +6.66% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $301.78 | +24.26% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $9.46 | +26.85% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $25.24 | +46.59% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $447.04 | -10.52% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $186.05 | -9.70% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $121.63 | +19.21% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $12.66 | +215.96% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $4.10 | +21.95% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.56 | - | 2 | Mar 7, 2024 |
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $28.53
Upside: +5.15%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $436.62
Upside: +32.84%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $362.50
Upside: -10.34%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $34.07
Upside: +26.21%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $290.65
Upside: +6.66%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $301.78
Upside: +24.26%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $9.46
Upside: +26.85%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $25.24
Upside: +46.59%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $447.04
Upside: -10.52%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $186.05
Upside: -9.70%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $121.63
Upside: +19.21%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $12.66
Upside: +215.96%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $4.10
Upside: +21.95%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.56
Upside: -